# Proteasomal-dependent endothelial P2Y6 receptor downregulation as an adaptive mechanism limiting monocyte adhesion during intestinal schistosomiasis

**Authors:** Nathalia F. Oliveira, Matheus M. L. V. Monteiro, Leticia D. Crepaldi, Robson Coutinho-Silva, Luiz Eduardo B. Savio, Claudia L. Martins Silva

PMC · DOI: 10.1007/s11302-026-10141-x · 2026-03-24

## TL;DR

This study shows that during intestinal schistosomiasis, endothelial cells reduce P2Y6 receptor levels via proteasomal degradation, which may help limit inflammation and tissue damage.

## Contribution

The paper identifies proteasomal-dependent downregulation of P2Y6 receptors in endothelial cells as a novel adaptive mechanism during schistosomiasis.

## Key findings

- P2Y6R expression is significantly downregulated in endothelial cells of infected mice.
- Proteasome inhibition restores P2Y6R expression and function in infected endothelial cells.
- ROS-dependent proteasome activation is linked to P2Y6R degradation during infection.

## Abstract

Schistosomiasis, a complex chronic intravascular parasitic disease caused by Schistosoma mansoni, triggers a multifaceted host immune response and drives endothelial cells toward a sustained proinflammatory phenotype. The dysfunctional endothelial cells are a hallmark event that contributes to intestinal and liver damage mainly due to an increased monocyte adhesion, but the elevated morbidity unveils the lack of knowledge about disease pathogenesis. Purinergic P2Y6 receptor (P2Y6R) expression is induced in some inflammatory models; therefore, we hypothesized that endothelial P2Y6R contributes to monocyte adhesion and mesenteric inflammation in S. mansoni-infected mice. Our results show that, unlike control mice, P2Y6R stimulation failed to enhance monocyte adhesion to endothelial cells from infected animals. Molecular analyses using RT-qPCR and immunocytochemistry revealed significant downregulation of P2Y6R expression in endothelial cells from the infected group at both transcript and protein levels. Importantly, pretreatment with a proteasome inhibitor restored both P2Y6R expression and function, implicating proteasomal degradation as a key mechanism underlying receptor loss during infection. Elevated lipid peroxidation in endothelial cells from the infected group further supported a role for reactive oxygen species (ROS)-dependent proteasome activation and receptor degradation. Collectively, these findings suggest that infection selectively modulates P2Y6R signaling by promoting proteasome-dependent downregulation of P2Y6R in endothelial cells, which could be an adaptive mechanism to reduce mesenteric inflammation and limit host tissue damage and morbidity during chronic infection.

## Linked entities

- **Proteins:** P2RY6 (pyrimidinergic receptor P2Y6)
- **Diseases:** schistosomiasis (MONDO:0015254), intestinal schistosomiasis (MONDO:0008412)
- **Species:** Schistosoma mansoni (taxon 6183), Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** Actb (actin, beta) [NCBI Gene 11461] {aka Actx, E430023M04Rik, beta-actin}, Adora2b (adenosine A2b receptor) [NCBI Gene 11541] {aka A2BAR, A2BR, A2b, AA2BR, ARA2B}, Entpd8 (ectonucleoside triphosphate diphosphohydrolase 8) [NCBI Gene 72090], Nfkb1 (nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105) [NCBI Gene 18033] {aka NF-KB1, NF-kappaB, NF-kappaB1, p105, p50, p50/p105}, P2ry6 (pyrimidinergic receptor P2Y, G-protein coupled, 6) [NCBI Gene 233571] {aka 2010204J23Rik, P2Y6}, Il1b (interleukin 1 beta) [NCBI Gene 16176] {aka IL-1beta, Il-1b}, Entpd3 (ectonucleoside triphosphate diphosphohydrolase 3) [NCBI Gene 215446] {aka Cd39l3, HB6, NTPDase-3}, Tnf (tumor necrosis factor) [NCBI Gene 21926] {aka DIF, TNF-a, TNF-alpha, TNFSF2, TNFalpha, Tnfa}, P2ry4 (pyrimidinergic receptor P2Y, G-protein coupled, 4) [NCBI Gene 57385] {aka P2Y4, P2Y4R}, P2ry2 (purinergic receptor P2Y, G-protein coupled 2) [NCBI Gene 18442] {aka P2U1, P2Y2}, Entpd2 (ectonucleoside triphosphate diphosphohydrolase 2) [NCBI Gene 12496] {aka Cd39l1, NTPDase2}, P2rx7 (purinergic receptor P2X, ligand-gated ion channel, 7) [NCBI Gene 18439] {aka P2X(7), P2X7R}, Pecam1 (platelet/endothelial cell adhesion molecule 1) [NCBI Gene 18613] {aka Cd31, PECAM-1, Pecam}, Gapdh (glyceraldehyde-3-phosphate dehydrogenase) [NCBI Gene 14433] {aka Gapd}, P2ry1 (purinergic receptor P2Y, G-protein coupled 1) [NCBI Gene 18441] {aka P2Y1, P2y1r}, VN1R17P (vomeronasal 1 receptor 17 pseudogene) [NCBI Gene 441931] {aka GPCR}, Gpbar1 (G protein-coupled bile acid receptor 1) [NCBI Gene 227289] {aka BG37, GPCR, GPR131, M-BAR, TGR5}, Entpd1 (ectonucleoside triphosphate diphosphohydrolase 1) [NCBI Gene 12495] {aka 2610206B08Rik, ATP-DPH, Cd39, E130009M23Rik, NTPDase-1}
- **Diseases:** mesenteric (MESH:D008639), neurodegenerative disorders (MESH:D019636), intravascular parasitic disease (MESH:D010272), atherosclerosis (MESH:D050197), Infections (MESH:D007239), chronic infection (MESH:D000088562), Schistosomiasis (MESH:D012552), colitis (MESH:D003092), infectious disease (MESH:D003141), inflammation (MESH:D007249), atherogenic vascular lesions (MESH:D014652), neglected tropical disease (MESH:D058069), intestinal schistosomiasis (MESH:D012555), liver damage (MESH:D056486), dislocation (MESH:D004204), cancer (MESH:D009369), chronic (MESH:D002908)
- **Chemicals:** uridine nucleotide (MESH:D014500), UDP (MESH:D014530), MG132 (MESH:C072553), paraformaldehyde (MESH:C003043), Glutamax (MESH:C054122), TBA (MESH:C029684), DAPI (MESH:C007293), formazan (MESH:D005562), Lipid (MESH:D008055), trichloroacetic acid (MESH:D014238), ADP (MESH:D000244), Alexa Fluor 488 (MESH:C000711379), serine (MESH:D012694), DMEM (-), SFB (MESH:C069226), streptomycin (MESH:D013307), O2 (MESH:D013481), NBT (MESH:D009580), MDA (MESH:D008315), Triton X-100 (MESH:D017830), ARL 67156 (MESH:C092431), NaHCO3 (MESH:D017693), KOH (MESH:C029943), CO2 (MESH:D002245), isothiocyanate (MESH:C037152), LPS (MESH:D008070), ATP (MESH:D000255), UTP (MESH:D014544), MRS2578 (MESH:C541384), sucrose (MESH:D013395), nucleotides (MESH:D009711), glucose (MESH:D005947), water (MESH:D014867), xylazine (MESH:D014991), ROS (MESH:D017382), diphosphates (MESH:D011756), cysteine (MESH:D003545), DMSO (MESH:D004121), penicillin (MESH:D010406)
- **Species:** Biomphalaria glabrata (bloodfluke planorb, species) [taxon 6526], Homo sapiens (human, species) [taxon 9606], Mus musculus (house mouse, species) [taxon 10090], Schistosoma mansoni (species) [taxon 6183]
- **Mutations:** A 26 S, serine/threonine
- **Cell lines:** HEK293 — Homo sapiens (Human), Transformed cell line (CVCL_0045)

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13013911/full.md

---
Source: https://tomesphere.com/paper/PMC13013911